Lv5
1050 积分 2023-08-23 加入
The predict factors and clinical prognosis value of immune-related pneumonia of receiving PD-1 inhibitor in advanced non-small cell lung cancer: A retrospective study
3小时前
已完结
Tumor invasion in the central airway is a risk factor for early‐onset checkpoint inhibitor pneumonitis in patients with non‐small cell lung cancer
3小时前
已完结
Predicting checkpoint inhibitors pneumonitis in non-small cell lung cancer using a dynamic online hypertension nomogram
3小时前
待确认
Impact of Baseline Interstitial Lung Abnormalities on Pneumonitis Risk in Patients Receiving Immune Checkpoint Inhibitors for Non–Small-Cell Lung Cancer
3小时前
已完结
A nomogram model for predicting the risk of checkpoint inhibitor‐related pneumonitis for patients with advanced non‐small‐cell lung cancer
4小时前
已完结
Immune checkpoint inhibitor-related pneumonitis: research advances in prediction and management
5小时前
已完结
Data-driven risk stratification and precision management of pulmonary nodules detected on chest computed tomography
4天前
已完结
Neoadjuvant immunotherapy strategies for resectable non-small cell lung cancer (NSCLC): Current evidence among special populations and future perspectives
12天前
已完结
Global Trends of Early, Middle, and Late‐Onset Lung Cancer From 1990 to 2021: Results From the Global Burden of Disease Study 2021
12天前
已完结
Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: a population-based study
12天前
已完结
皖公网安备34019202002308
